Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the practical patient care editorial team, identify the main drivers of the industry helping to produce regular, thought provoking opinion pieces on the latest issues, challenges and developments.

Latest Practical Patient Care Feature

The positives of a negative margin
09 November, 2022
Surgical resection of cancerous tissue tends to include a “safety margin”...
> read more

The paradigm shift 09 November, 2022 Checkpoint inhibitors have revolutionised cancer care. Stimulating the immune system is now as much of a focus in oncology as killing or surgically removing cancers. It’s a more...

The positive test 09 November, 2022 The Covid-19 pandemic provided the impetus for unprecedented speed in the development of testing methods, as the industry collaborated, and regulators worldwide supported their...

The next phage 09 November, 2022 While bacteria are responsible for a laundry list of diseases, they have their own enemy in the form of bacteriophages (viruses that infect bacteria). In turn, bacteriophages might...

Monkeying around 09 November, 2022 It’s always been a cliché that bad things happen in pairs – and the arrival of monkeypox just as the Covid pandemic began to recede has done little to disprove the theory. But beyond...

The aftershock 09 November, 2022 Septic shock is the most severe result of sepsis – an overreaction from the immune system to bacterial, fungal or viral infection. As with other acute conditions, time is of the...

Pressure point 09 November, 2022 Pressure ulcers are among the most serious dangers to bedbound hospital and care home patients, which makes sense if you understand how they form. Developing from the pressure caused...

US FDA approves Pfizer-BioNTech, Moderna Covid-19 vaccines for kids aged six months 20 June, 2022 The US agency expanded EUAs for the Pfizer-BioNTech and Moderna Covid-19 vaccines to include their use in children aged six months to four years, and six months to 17 years, respectively

Roche gets EC approval for Lunsumio to treat follicular lymphoma 14 June, 2022 The EC approval is based on positive results from the Phase ½ GO29781 study, which assessed the safety, efficacy and pharmacokinetics of Lunsumio in people with B-cell non-Hodgkin lymphoma

Pfizer wraps up acquisition of RSV therapeutics company ReViral 14 June, 2022 The acquisition will provide Pfizer with ReViral’s portfolio of therapeutic candidates, including sisunatovir, along with another lead candidate, focused on RSV replication

US FDA requires patient notification about suicide risk related to finasteride 14 June, 2022 The US regulator required a patient notification about suicidal behaviour, where it has previously approved an expanded its label indication to include risks of persistent...

GSK’s RSV vaccine for older adults shows positive outcomes in Phase 3 trial 14 June, 2022 The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults aged 60 years and above

Amylyx secures Health Canada approval for Albrioza to treat ALS 14 June, 2022 Albrioza, also known as AMX0035, is an oral fixed-dose combination therapy that works to reduce neuronal cell death and is the first new ALS therapy approved in Canada since 2018

Weaponising data to fight infection in hospitals 13 May, 2022 Healthcare-associated infections are one of the greatest preventable threats to patient safety. In addition to causing suffering, they can do lasting, economic damage to...

Laser photobiomodulation for faster healing and pain management 13 May, 2022 Light therapy has been increasingly used for a wide variety of medical applications. However, treatments for wound healing and pain management are the most commonly used applications...

Battling the resistance 13 May, 2022 Abbott is an expert in the use of rapid diagnostics to help combat antimicrobial resistance globally, and has a refined understanding of the role education plays in enabling...

Putting antibiotic resistance to the test 13 May, 2022 Just like other organisms, disease-causing bacteria evolve defence mechanisms that allow it to survive when patients are treated with antibiotics. A liberal approach to prescribing...

Embracing preanalytics for better diagnostics 13 May, 2022 When swabbing became an all-too-familiar experience, testing and screening were understood as vital processes in the fight against viral infection. Sampling was identified as a...

Complete test portfolio for Lyme disease diagnostics 13 May, 2022 A comprehensive portfolio of Borrelia antibody test systems from EUROIMMUN enables qualified two-step Lyme disease diagnostics according to the latest recommendations. Screening...

A rapid response to the pandemic 13 May, 2022 As the world continues to deal with Covid-19, quick and accurate testing is still one of the best ways to slow its spread and protect the most vulnerable in our communities....


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.